[Pharmacology of 6-methyl-7-diethylamino-s-triazolo-(1,5-a) pyrimidine (Trapymin, Rocornal), a new compound with vasodilative effects].
D000818:Animals; D001783:Blood Flow Velocity; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D002417:Cattle; D003326:Coronary Circulation / Q000187:drug effects; D004231:Diuresis / Q000187:drug effects; D004562:Electrocardiography; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D051379:Mice; D011743:Pyrimidines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D013552:Swine; D014230:Triazoles / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000633:toxicity
D001786:Blood Glucose; D011743:Pyrimidines; D014230:Triazoles; D014665:Vasodilator Agents
Pharmakologie des 5-Methyl-7-diamino-s-triazolo (1.5-a) pyrimidin (Trapymin, Rocornal), einer Verbindung mit koronargefässerweiternder Wirkung.